Scholars Central

Conference abstract

Using specific response towards environment as a selective marker for therapy in breast cancer cells

Authors: Hsiu-Ni Kung

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Breast cancer heterogeneity occurs as a consequence of the dysregulation of oncogenic and non-genetic factors, including tumor microenvironmental stresses. Although the non-genetic factors are important, it is not clear how to integrate these factors within the genetic framework of cancer as the next step in understanding tumor heterogeneity. In the first part, series of gene expression signatures were developed to examine the influences of microenvironmental stresses. Through the integrative pathway analysis of microenvironmental stresses and oncogenic events in breast tumors, we identify many known and novel correlations. We further determine two subgroups, which have features consistent with basal and luminal breast tumors including patterns of oncogenic signaling pathways and cellular mechanisms that regulate the hypoxia response, in HER2 breast cancers. Although significant variations in the metabolic profiles exist among different cells, little is understood in genetic regulations of cell type-specific metabolism and nutrient requirements. While cancer cells depend on exogenous glutamine for survival, the mechanisms of glutamine dependence, the response and resistance of glutamine-targeting strategies among cancers are largely unknown. In the second part, we find a systematic variation in the glutamine dependence among breast tumor subtypes: basalbut not luminal-type breast cells are more glutamine-dependent and may be susceptible to glutamine-targeting therapeutics. The ability of glutamine synthetase to predict patterns of glutamine metabolism and dependency among tumors is also crucial in the rational design and application of glutamine targeted therapies. Taking two studies together, results demonstrate the potential of genetic and non-genetic factors to investigate the basis of tumor heterogeneity.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Pharmacogenomics & Pharmacoproteomics.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Pharmacogenomics & Pharmacoproteomics
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Hsiu-Ni Kung”